Cullen/Frost Bankers, Inc. Amneal Pharmaceuticals, Inc. Transaction History
Cullen/Frost Bankers, Inc.
- $7.23 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$196 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$132 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$102 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.36B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...